Hims & Hers Health (HIMS) Cash from Restructuring (2022 - 2026)
Hims & Hers Health (HIMS) posted Cash from Restructuring of $6.4 million for Q1 2026, up 583.15% sequentially from $932000.0 in Q4 2025, and up 518.16% YoY from $1.0 million in Q1 2025.
Hims & Hers Health (HIMS) Cash from Restructuring (2022 - 2026) Analysis & Trends
Hims & Hers Health has reported Cash from Restructuring for 4 years, with the latest figure at $6.4 million in Q1 2026.
- Quarterly Cash from Restructuring rose 518.16% year-over-year to $6.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.2 million (up 990.29% YoY) and the FY2025 annual result came in at $5.9 million, changed N/A from the prior year.
- Cash from Restructuring grew to $6.4 million in Q1 2026 per HIMS's latest filing, from $932000.0 in the prior quarter.
- Over five years, Cash from Restructuring peaked at $6.4 million in Q1 2026 and troughed at -$256000.0 in Q3 2022.
- A 4-year average of $1.2 million and a median of $932000.0 in 2025 frame the typical range for Cash from Restructuring.
- The widest YoY moves for Cash from Restructuring: up 4645.45% in 2023, down 58.74% in 2023.
- Over 4 years, Cash from Restructuring stood at $1.0 million in 2022, then tumbled by 58.74% to $427000.0 in 2023, then jumped by 118.27% to $932000.0 in 2025, then soared by 583.15% to $6.4 million in 2026.
- According to Business Quant data, Cash from Restructuring over the past three periods registered $6.4 million, $932000.0, and $2.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Hims & Hers Health | 7.42 Bn | 6.57 Bn | 480.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.94 Mn |
| Mar 31, 2026 | 6.37 Mn |
| Dec 31, 2025 | 932,000.00 |
| Sep 30, 2025 | 1.98 Mn |
| Jun 30, 2025 | 1.96 Mn |
| Mar 31, 2025 | 1.03 Mn |
| Dec 31, 2023 | 427,000.00 |
| Sep 30, 2023 | 1.20 Mn |
| Jun 30, 2023 | 500,000.00 |
| Mar 31, 2023 | 566,000.00 |
| Dec 31, 2022 | 1.04 Mn |
| Sep 30, 2022 | -256,000.00 |
| Jun 30, 2022 | -11,000.00 |
| Mar 31, 2022 | 69,000.00 |